Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

25 June 2025 : Clinical Research  

Differentiating Between Methylphenidate Use and Misuse: Clinical Insights From University Students and Academic Staff in Türkiye

Meltem Gürü ABCDEFG 1*

DOI: 10.12659/MSM.948984

Med Sci Monit 2025; 31:e948984

Table 1 Sociodemographic and clinical characteristics of individuals seeking methylphenidate (n=135) at a university-based psychiatric clinic, by ADHD diagnosis and misuse pattern.

Variable/GroupADHD-diagnosed misusersADHD-diagnosed non-misusersNon-ADHD misusersNon-ADHD non-misusers
n (%)4 (3%)45 (33.3%)16 (11.9%)70 (51.8%)
Median age (min–max)24 (19–29)22 (18–33)25.5 (23–32)25 (19–55)
Gender n (%)Female2 (50%)20 (44.4%)4 (25%)36 (51.4%)
Male2 (50%)25 (55.6%)12 (75%)34 (48.6%)
Educational level n (%)University3 (75%)39 (86.7%)9 (56.2%)40 (57.1%)
Master’s1 (25%)5 (11.1%)0 (0%)17 (24.3%)
PhD0 (0%)1 (2.2%)7 (43.8%)12 (17.1%)
Professor0 (0%)0 (0%)0 (0%)1 (1.4%)
Repeating a grade4 (100%)16 (35.6%)7 (43.8%)28 (40%)
Median age of onset (min–max) for cases with attention deficit14 (7–15)14 (5–20)20 (17–25)20 (15–45)
Cigarette smoking4 (100%)18 (40%)15 (93.8%)41 (58.6%)
Alcohol use disorder2 (50%)0 (0%)5 (31.3%)8 (11.4%)
Substance use disorder3 (75%)3 (6.7%)4 (25%)4 (5.7%)
Presence of psychiatric disorders in the family4 (100%)30 (66.7%)2 (12.5%)18 (25.7%)
MedicationShort-acting MPH1 (25%)9 (20%)12 (75%)51 (72.8%)
Intermediate-acting MPH0 (0%)15 (33.3%)0 (0%)0 (0%)
Long-acting MPH0 (0%)16 (35.6%)1 (6.3%)13 (18.6%)
Multiple MPH formulations3 (75%)5 (11.1%)3 (18.7%)6 (8.6%)
Primary source of information about MPHPsychiatrist4 (100%)42 (93.3%)0 (0%)0 (0%)
Peers0 (0%)2 (4.4%)15 (93.8%)40 (57.1%)
Internet/social media0 (0%)1 (2.3%)0 (0%)19 (27.1%)
Instructors0 (0%)0 (0%)1 (6.2%)11 (15.8%)
MPH sharing4 (100%)3 (6.7%)14 (87.5%)0 (0%)
Follow-up attendance2 (50%)44 (97.8%)2 (12.5%)26 (37.1%)
ADHD – Attention Deficit Hyperactivity Disorder; min – minimum; max – maximum; PhD – Doctor of Philosophy; Prof – Professor; MPH – methylphenidate.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750